Among positive samples, an intense stain in 40% of cells or more (high positivity) was present in 8 cases (40%), whereas the remaining 12 samples (60%) were positive in less than 40% of tumor population (low positivity), or presented a focal survivin staining (Figure 1A and B). The gene discussed is BIRC5; the disease is neoplasm.